Full text is available at the source.
Abstract
The CRISPR-Cas12a system enables sensitive nucleic acid detection due to its programmability, trans-cleavage activity, and biocompatibility.
- Aptamers are recognized as effective recognition elements due to their high specificity and flexibility in design.
- Integrating Cas12a with aptamers allows for the conversion of target-binding signals into nucleic acid recognition signals.
- This combination facilitates signal amplification for the detection of non-nucleic acid targets.
- Recent advances include the development of Cas12a-aptamer-based fluorescent biosensors aimed at serum biomarker detection.
- The review discusses advantages, limitations, current challenges, and future prospects of the Cas12a system.
Simplified